Cytokines elicited by T cell epitopes from a synovial autoantigen: Altered peptide ligands can reduce interferon‐γ and interleukin‐10 production
Open Access
- 1 August 2003
- journal article
- research article
- Published by Wiley in Arthritis & Rheumatism
- Vol. 48 (8) , 2375-2385
- https://doi.org/10.1002/art.11132
Abstract
Objective To explore the cytokine responses associated with T cell epitopes from human cartilage glycoprotein 39 (HC gp‐39) and the potential for modifying cytokine secretion using altered peptide ligands (APLs). Methods Draining lymph node cells were harvested from HLA–DR*0401 transgenic mice that had been immunized with HC gp‐39. Cytokine responses to 5 previously identified HLA–DR*0401–restricted HC gp‐39 T cell epitopes were studied in vitro. The anchor and T cell receptor (TCR) contact residues of peptide 322–337 were identified, and this information was used to design alanine‐substituted APLs. T cells were primed in vivo with wild‐type peptide 322–337, restimulated with wild‐type peptide or APLs, and the cytokine profiles were compared. Results Restimulation with individual peptides elicited distinct cytokine profiles. HC gp‐39 (peptide 322–337) elicited a dominant interferon‐γ (IFNγ) response. Residues within the core (positions P1–P9) 322–337 peptide sequence were critical for T cell recognition. Surprisingly, the N‐terminal flanking region was also important for recognition by 6 of 10 specific T cell hybridomas. Substitutions of charged TCR contact residues in the 322–337 core epitope (E332A and K335A) were associated with a significant reduction in the IFNγ and interleukin‐10 (IL‐10) stimulation indices. Restimulation with peptides W325A and V326A was also associated with a trend toward reduced IFNγ and IL‐10 secretion. In contrast, restimulation with peptide D330N elicited cytokine profiles more comparable with those resulting from restimulation with wild‐type peptide. Conclusion This study indicates that APLs of a proinflammatory HC gp‐39 T cell epitope may be used to alter the cytokine response from a memory T cell population.Keywords
Funding Information
- Arthritis Research Campaign (UK)
- NIH (AR-44647, DK-54364, R01-AI-13587-26, AI-28809, AR-44647, DK-54364)
- Arthritis Foundation
This publication has 34 references indexed in Scilit:
- Recognition of core and flanking amino acids of MHC class II-bound peptides by the T cell receptorEuropean Journal of Immunology, 2002
- Relationship between kinetic stability and immunogenicity of HLA-DR4/peptide complexesEuropean Journal of Immunology, 2002
- pH Stability of HLA-DR4 Complexes with Antigenic PeptidesBiochemistry, 2000
- Raised human cartilage glycoprotein-39 plasma levels in patients with rheumatoid arthritis and other inflammatory conditionsAnnals of the Rheumatic Diseases, 2000
- Regulatory T Cells in AutoimmmunityAnnual Review of Immunology, 2000
- The expanding universe of T-cell subsets: Th1, Th2 and morePublished by Elsevier ,1999
- The Distribution of YKL-40 in Osteoarthritic and Normal Human Articular CartilageScandinavian Journal of Rheumatology, 1999
- Role of interleukin‐4 and interleukin‐10 in murine collagen‐induced arthritis. Protective effect of interleukin‐4 and interleukin‐10 treatment on cartilage destructionArthritis & Rheumatism, 1997
- Treatment of experimental encephalomyelitis with a peptide analogue of myelin basic proteinNature, 1996
- Published by American Association for the Advancement of Science (AAAS) ,1994